PL-13
PL-13 (Compound P11) is the derivative of Trabectedin. PL-13 can disrupt the function of DNA and induces apoptosis in cancer cells. PL-13 be can be used for the research of cancer[1].
Product Specifications
UNSPSC
12352005
Target
ADC Payload; Apoptosis; Drug Derivative
Related Pathways
Antibody-drug Conjugate/ADC Related; Apoptosis; Others
Field of Research
Cancer
Smiles
N#C[C@@H]([C@]1([H])CC2=CC(C)=C3OC)N([C@](CO4)([H])C5=C(OCO6)C6=C7C)[C@@]([C@@](N1C)([H])C2=C3O)([H])[C@@](SC[C@](C8=CC(OC)=C9NC(CN)=O)(NCCC8=C9)C4=O)([H])C5=C7OC(C)=O
Molecular Formula
C42H46N6O10S
Molecular Weight
826.91
References & Citations
[1]Bin Zou, et al. Anti-alpp/alppl2 antibodies, antibody-drug conjugates, and uses thereof. WO2025048716A1. 2025-03-06.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-171715/
Scientific Category
ADC Related
Clinical Information
No Development Reported
CAS Number
[3056740-00-9]
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
